Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Unicycive Therapeutics, Inc. (UNCY)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1/A
Revenues  1.00.00.00.8
            Revenue growth    -100.0% 
Cost of goods sold  -19.00.00.02.0
Gross profit  20.00.00.0-1.2
            Gross margin  2098.8%  -146.9%
Selling, general and administrative   [+]6.62.91.01.2
Research and development  12.46.11.0 
Other operating expenses  19.0  -0.4
EBITDA   [+]-18.0-9.0  
            EBITDA margin  -1897.5%  -246.9%
Depreciation and amortization  0.00.0  
EBIT   [+]-18.1-9.0-2.0-2.0
            EBIT margin  -1898.2%  -246.9%
Interest expense  0.00.60.20.1
Other income (expense), net   [+] -0.4 -0.1
Pre-tax income  -18.1-10.0-2.3-2.2
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -18.1-10.0-2.3-2.2
            Net margin  -1898.8%  -272.3%
   
Basic EPS   [+]($1.20)($0.86)($0.27)($0.27)
Diluted EPS   [+]($1.20)($0.86)($0.27)($0.27)
   
Shares outstanding (basic)   [+]15.111.78.58.1
Shares outstanding (diluted)   [+]15.111.78.58.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy